Evidence map›Paper›PMID 41979831›Full record

ArticleGeroScience2026

Bidirectional associations between biological aging, cardiovascular health, and cardiovascular risk: findings from the INSPIRE-T lifespan cohort.

Mathilde Strumia, Vanina Bongard, Samuel Thuriot, Philippe Cestac, Brigitte Sallerin, Jean-Marc Lemaitre, David Furman, Sophie Guyonnet, Bruno Vellas, Sandrine Andrieu and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mathilde StrumiaCERPOP, Université de Toulouse, Inserm, Université de Toulouse, Toulouse, France. strumia.m@chu-toulouse.fr.ORCID http://orcid.org/0000-0002-5622-2206
Vanina BongardCERPOP, Université de Toulouse, Inserm, Université de Toulouse, Toulouse, France.
Samuel ThuriotCERPOP, Université de Toulouse, Inserm, Université de Toulouse, Toulouse, France.
Philippe CestacCERPOP, Université de Toulouse, Inserm, Université de Toulouse, Toulouse, France.
Brigitte SallerinDépartement de Pharmacie Clinique, Centre Hospitalier Universitaire de Toulouse, 330 Avenue de Grande Bretagne, 31300, Toulouse, France.
Jean-Marc LemaitreNSERM IRMB UMR1183, Hôpital Saint Eloi, Université de Montpellier, Montpellier, France.
David FurmanBuck Artificial Intelligence Platform, the Buck Institute for Research On Ageing, Novato, USA.
Sophie GuyonnetCERPOP, Université de Toulouse, Inserm, Université de Toulouse, Toulouse, France.
Bruno VellasCERPOP, Université de Toulouse, Inserm, Université de Toulouse, Toulouse, France.
Sandrine AndrieuCERPOP, Université de Toulouse, Inserm, Université de Toulouse, Toulouse, France.
Laure RouchCERPOP, Université de Toulouse, Inserm, Université de Toulouse, Toulouse, France.
I. H. U. HealthAge INSPIRE/Open Science group

Funding

Agence Nationale de la Recherche ANR-23-IAHU-0011European Regional Development Fund MP0022856Région Occitanie Pyrénées-Méditerranée 1901175
6 · The paper itself

Abstract

Chronological age is a common and non-modifiable factor for chronic disease, but does not fully explain age-related changes. Biological clocks have been developed to explore biological aging mechanisms. They could help identify protective factors against accelerated aging and associated diseases. We aim to assess the association between reduced epigenetic or inflammatory aging and ideal cardiovascular health or cardiovascular risk. We conducted a cross-sectional analysis of participants from the INSPIRE-T cohort. Cardiovascular health (CVH) was assessed using the Life's Essential 8 score. Cardiovascular risk was assessed using the American Framingham risk score (FRS) and the European Systematic Coronary Risk Evaluation (SCORE2) score. Epigenetic and inflammatory aging was calculated from the residuals from linear regression of biological age (based on five epigenetic clocks and one inflammatory clock) and chronological age. Linear and logistic regression models were used. Better CVH has been associated with slower epigenetic aging, particularly in younger subjects and men. Accelerated epigenetic aging measured by GrimAge was associated with an increase cardiovascular risk (for SCORE2: OR = 1.10 95%CI [1.04; 1.16]). No persistent association was found with the inflammatory clock. Our study reported an association between ideal global CVH with reduced epigenetic aging after adjustment for chronological age and gender. This suggests that epigenetic aging may be modifiable through healthy lifestyle and cardiovascular risk management, although a potential underlying causal relationship remains to be established. Moreover, accelerated epigenetic aging is linked to worsening cardiovascular risk, and could be a new risk factor alongside chronological age.

Indexed as

Cardiovascular healthCardiovascular riskEpigenetic agingInflammatory agingLife’s Essential 8

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.